We selected two lung cancer cell lines that exhibit mutations in EGFR to confirm the respective sensitivities of the UDP and enrichment PCR-UDP methods, namely PC-9 cells, which possess a deletion in exon 19 (E19del), and H197 cells, which contain a substitution mutation (L858R) in exon 21. The gene discussed is EGFR; the disease is lung cancer.